Halozyme Therapeutics HALO All other foreign — Total revenues

Similar metrics at other companies

HAll foreign — Total revenues

$536.5M+33.1%

EBSAll other revenue — Total revenues

$13.9M-7.3%

NDAQAll other countries — Total revenues

$627M+56.0%

GEHCAll other countries — Total revenues

$2.36B+5.7%

INNVAll other — Total revenues

$0-100%

CHHForeign Operations — Total revenues

$29.45M+14.7%

FAQ

What is Halozyme Therapeutics's all other foreign — total revenues?

Halozyme Therapeutics (HALO) reported all other foreign — total revenues of $8.33M in Q4 2025.

How has Halozyme Therapeutics's all other foreign — total revenues changed year-over-year?

Halozyme Therapeutics's all other foreign — total revenues increased by 249.9% year-over-year, from $2.38M to $8.33M.

What is the long-term trend for Halozyme Therapeutics's all other foreign — total revenues?

Over 4 years (2021 to 2025), Halozyme Therapeutics's all other foreign — total revenues has grown at a 70.2% compound annual growth rate (CAGR), from $3.97M to $33.33M.

What does all other foreign — total revenues mean?

This metric represents the total revenue generated from geographic regions outside of the company's primary markets that do not meet the quantitative thresholds for individual segment reporting. It captures the aggregate financial contribution from smaller international territories where the company maintains commercial operations or licensing agreements. Tracking this revenue helps investors assess the company's ability to monetize its intellectual property or products in emerging or secondary global markets.